Athira Pharma, Inc. - Common Stock (ATHA)
0.2645
-0.0155 (-5.54%)
NASDAQ · Last Trade: Apr 3rd, 11:43 AM EDT

Via Benzinga · November 5, 2024

Via Benzinga · November 1, 2024

Via Benzinga · November 1, 2024

Via Benzinga · November 1, 2024

Via Benzinga · September 6, 2022

Athira Pharma (NASDAQ:ATHA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via Benzinga · August 15, 2022

Via Benzinga · October 31, 2024

Via Benzinga · September 19, 2024

Via Benzinga · September 4, 2024

Athira Pharma stock falls as the company reports mixed results from its Phase 2/3 LIFT-AD clinical trial for Alzheimer's treatment fosgonimeton, with data showing directional improvements but no statistical significance in key outcomes.
Via Benzinga · September 4, 2024

Via Benzinga · September 4, 2024

ATHA stock results show that Athira Pharma beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 1, 2024

ATHA stock results show that Athira Pharma beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 15, 2024

Via Benzinga · March 27, 2024

The Dow Jones index closed lower by around 20 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · January 2, 2024

Extensive research on NDDs has uncovered a different treatment pathway that's enabling some biotechnology firms to target more than one NDD with the same drug candidate.
Via Talk Markets · September 21, 2023

Via Benzinga · June 12, 2023

The Dow Jones closed higher by around 10 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · June 7, 2023

The Dow Jones closed higher by more than 400 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · April 3, 2023

US stocks recorded losses for 2022. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · January 3, 2023

The Dow Jones closed lower by nearly 350 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · December 7, 2022

US crude oil futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · November 18, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:
Via Benzinga · July 5, 2022

Upgrades
Via Benzinga · July 7, 2022